Agenda           Committee       

Innovations in point-of-care (POC) diagnostic research are poised to revolutionize healthcare domestically and globally. The field is expanding rapidly and is beginning to impact patient care.

Click for Full Recording - Please refer to the Agenda linked above for timing

 

Keynote Speaker:
Utkan Demirci Ph.D.
Associate Professor of Radiology
Stanford Medicine

Label-free Magnetic Levitation Technologies
for Monitoring Health and Disease

Winston Kuo, DMSc President Predicine Holdings, Ltd

Winston Kuo, DMSc
President
Predicine Holdings, Ltd

Claudia Campbell-Matland Consultant and Managing Member CNCM Consulting, LLC

Claudia Campbell-Matland
Consultant and Managing Member
CNCM Consulting, LLC

Tom White Scientific Advisor Foundation for Innovative New Diagnostics (FIND)

Tom White
Scientific Advisor
Foundation for Innovative New Diagnostics (FIND)

Arjun Ganesan CEO, Ancera

Arjun Ganesan
CEO,
Ancera

Barbara Smith Ph.D. Assistant Professor School of Biological and Health Systems Engineering Arizona State University

Barbara Smith Ph.D.
Assistant Professor
School of Biological and Health Systems Engineering
Arizona State University

Matthew Lei Ph.D. CEO QuanDx

Matthew Lei Ph.D.
CEO
QuanDx

Paul S. Savuto President & CFO Blinded Diagnostics

Paul S. Savuto
President & CFO
Blinded Diagnostics

Peggy Mann
Clinics Quality, Safety, Environment Program Manager & POCC
University of Texas Medical Branch

Salvatore Russello Ph.D. Associate Director, Global Business Development New England Biolabs

Salvatore Russello Ph.D.
Associate Director, Global Business Development
New England Biolabs

Ying Pan Ph.D. Research Associate Stanford University School of Medicine

Ying Pan Ph.D.
Research Associate
Stanford University School of Medicine

Umut Atakan Gurkan Ph.D. ASSISTANT PROFESSOR Case Western Reserve University

Umut Atakan Gurkan Ph.D.
ASSISTANT PROFESSOR
Case Western Reserve University

Michael Gavin President PortaScience

Michael Gavin
President
PortaScience

Thank you to our partner

Thank you to our partner

This one-day online Symposium will address these issues from multiple perspectives, enhancing cross-silo discussions and knowledge sharing on ways that POC device developers are overcoming hurdles in implementation:

Accelerated growth of cross-disciplinary teams supports the intersection of biomedicine, bioengineering, biophysics, physical and biological chemistry, nanotechnology and physiology, all while leveraging broad applications in detecting, screening and monitoring diseases. Fresh data and solutions are enabling drug development, new discoveries, and advances that are inexpensive yet highly effective.

Full implementation of POC diagnostic devices has frequently been stymied by a number of factors, including the lack of a clear regulatory process, private sector interest, standards and ready means of distribution. As a result, the millions of dollars spent on research and development of these cutting edge devices rarely make it to the field where they are needed the most.